Tag Archive: Cato BioVentures

Nov 06

New FDA Guidances for October 2015

By Brant Hamel, Ph.D., Regulatory Scientist at Cato Research FDA draft and final guidances, released from CDER, CBER, and CDRH in October 2015, are posted.  In addition, upcoming advisory committee meetings to be held are also listed below with a link to more information. Special Interest Guidances/Information Date Posted Liposome Drug Products: Chemistry, Manufacturing, and …

Continue reading »

Jun 28

Biotech Funding: Still Playing Hard-to-Get

After a few lean years, biotechs raised $25 billion in 2010.  For the majority of small companies however, funding remains difficult to find.  Ernst & Young’s annual report on the biotechnology industry, Beyond Borders, was recently released and it paints a less rosy picture than the $25 billion number would appear to. It turns out …

Continue reading »

May 27

Bridging the Valley of Death: Bringing New Drugs from the Bench to the Clinic

Bridge

To bring a new medicine to the stage of clinical trial testing requires on the order of $500,000 to one million dollars and then seven to ten years of clinical trials and around $800 million dollars before getting to market.  However, it is doable, and one can point to successful biotechs such as Genentech, Amgen, …

Continue reading »

May 11

Conference Recap – BayBio 2011

The BayBio Annual Conference 2011 was held on 20-21 April 2011 in Burlingame, CA.  The event was attended by more than 1,000 San Francisco Bay Area biotech and life sciences professionals from over 400 companies. This year’s conference focused on funding trends and emerging markets in the life sciences industry.  In keeping with BayBio’s spirit …

Continue reading »

Feb 28

Recap of the 20th CED Biotech/Life Sciences Conference

The 20th Annual Council for Entrepreneurial Development (CED) Biotech/Life Science Conference was held on 21-22 February 2011 in Raleigh, North Carolina.

Dec 07

Biotech Financing: Those That Adapt to Change Will Survive

In the October issue of Biotechnology Focus, Cato Research’s very own Chief Financial Officer and Principal of Cato BioVentures, Daniel Pharand, discusses the recent shift and latest trends in financing within the biotechnology industry.  “There have been a number of trends in the biotech funding world since its last bubble and bust in the early …

Continue reading »

Oct 26

2010 Mid-Atlantic Bio Conference

Image via Wikipedia The 2010 Mid-Atlantic Bio conference will be held in Bethesda, MD from Wednesday, 27 October to Friday, 29 October.  Mid-Atlantic Bio is now in its sixth year and has become one of the country’s premier bioscience and investor conferences. The Mid-Atlantic Bio conference program combines networking events and education sessions to offer …

Continue reading »

Sep 23

35th European Society for Medical Oncology Congress

Image via Wikipedia The annual European Society for Medical Oncology (ESMO) meeting brings together medical oncologists from both Europe and all parts of the world.  As per ESMO’s 2010 meeting President, Dr. David Kerr, announcement: The ESMO Congress is a magnetic meeting point for worldwide medical oncology specialists and the ideal forum to present and …

Continue reading »

Jul 01

Use A Detailed Development Plan to Secure Venture Capital

It’s a tough time to be asking for money.  Whether you’re a high schooler who needs cash to gas up the ride or a fledgling biotechnology company with a hot technology, there’s not much extra to go around.  In today’s stiflingly competitive biotechnology financing market an on-target presentation to a potential investor can make the …

Continue reading »

May 12

Approval of Therapeutic Cancer Vaccines

Last month, Dendreon was granted approval for Provenge®, the first cell based cancer vaccine for treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.  Provenge is the first cancer treatment that utilizes the strength of the patient’s own immune system to fight tumors.  This approval could mark the beginning of a …

Continue reading »

Older posts «